...
首页> 外文期刊>Gynecologic Oncology: An International Journal >Whence epithelial ovarian carcinoma?
【24h】

Whence epithelial ovarian carcinoma?

机译:卵巢上皮癌从何而来?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Among common malignancies, epithelial ovarian carcinoma (EOC) remains enigmatic in at least two important respects. First, the histologic region of origin for this cancer remains obscure and second, an identifiable premalignant or precursor lesion that is generally recognized by cancer pathologists is yet to be defined. This state of uncertainty is particularly problematic since the majority of these cancers are diagnosed at an advanced stage, leading directly to the high mortality to incidence ratio associated with EOC, which accounts for more deaths than all other gynecologic malignancies combined . The good prognosis for patients with disease confined to the ovary suggests that early detection could lessen mortality substantially. The use of serum CA-125 measurements and radiologic technology, alone or in combination, has yet to prove effective in either the high risk or general populations , although the detection of diagnostic serum proteomic patterns or biomarker panels holds promise in this context. In the genetically predisposed population, prophylactic bilateral salpingo-ophor-ectomy is a highly effective preventive measure, but is not without morbidity, side effects, and a residual risk of pelvic malignancy . Development of optimal primary and secondary prevention strategies for EOC in the high-risk and general populations would, presumably, be greatly facilitated by an improved understanding of its early natural history.
机译:在常见的恶性肿瘤中,至少在两个重要方面,上皮性卵巢癌(EOC)仍然是谜。首先,该癌症的组织学起源区域仍然不清楚,其次,尚待确定癌症病理学家通常公认的可识别的癌前病变或前体病变。这种不确定性状态尤其成问题,因为这些癌症中的大多数都是在晚期被诊断出来的,直接导致与EOC相关的高死亡率与发病率之比,这比所有其他妇科恶性肿瘤加起来造成的死亡率更高。对于局限于卵巢的疾病患者,良好的预后提示早期发现可以大大降低死亡率。尽管在这种情况下检测血清蛋白组学诊断模式或生物标志物具有广阔的前景,但单独使用或联合使用血清CA-125测量和放射学技术在高风险人群或普通人群中尚未证明有效。在遗传易感人群中,预防性双侧输卵管卵巢切除术是一种非常有效的预防措施,但并非没有发病率,副作用和残留盆腔恶性肿瘤的风险。据推测,通过更好地了解其早期自然历史,将极大地促进在高风险人群和普通人群中开发最佳的一级和二级预防策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号